Literature DB >> 13428681

Use of HeLa cells infected with tubercle bacilli for the study of antituberculous drugs.

C C SHEPARD.   

Abstract

Keywords:  DRUGS; MYCOBACTERIUM TUBERCULOSIS/effect of drugs on

Mesh：

Substances：

Year:  1957        PMID： 13428681      PMCID： PMC314607          DOI： 10.1128/jb.73.4.494-498.1957

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


× No keyword cloud information.
  10 in total

1.  Activities and responses of living cells and their components as recorded by cinephase microscopy and electron microscopy.

Authors:  G O GEY; P SHAPRAS; E BORYSKO
Journal:  Ann N Y Acad Sci       Date:  1954-11-17       Impact factor: 5.691

2.  Phagocytosis by HeLa cells and their susceptibility to infection by human tubercle bacilli.

Authors:  C C SHEPARD
Journal:  Proc Soc Exp Biol Med       Date:  1955-11

3.  Cycloserine: antituberculous activity in vitro and in the experimental animal.

Authors:  W STEENKEN; E WOLINSKY
Journal:  Am Rev Tuberc       Date:  1956-04

4.  Antibiotics.

Authors:  H EAGLE; A K SAZ
Journal:  Annu Rev Microbiol       Date:  1955       Impact factor: 15.500

5.  Antituberculous activity of tetracycline and related compounds.

Authors:  G L HOBBY; T F LENERT
Journal:  Am Rev Tuberc       Date:  1955-09

6.  The action of drugs on intracellular tubercle bacilli.

Authors:  G B MACKANESS
Journal:  J Pathol Bacteriol       Date:  1952-07

7.  The action of isoniazid (isonicotinic acid hydrazide) on intracellular tubercle bacilli.

Authors:  G B MACKANESS; N SMITH
Journal:  Am Rev Tuberc       Date:  1952-08

8.  Activation of pyrazinamide and nicotinamide in acidic environments in vitro.

Authors:  W McDERMOTT; R TOMPSETT
Journal:  Am Rev Tuberc       Date:  1954-10

9.  Multiplication of tubercle bacilli within phagocytes cultivated in vitro, and effect of streptomycin and isonicotinic acid hydrazide.

Authors:  E SUTER
Journal:  Am Rev Tuberc       Date:  1952-06

10.  The protection of intracellular brucella against streptomycin alone and in combination with other antibiotics.

Authors:  R L MAGOFFIN; W W SPINK
Journal:  J Lab Clin Med       Date:  1951-06
  10 in total
  11 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  [The so-called atypical mycobacteria].

Authors:  E FREERKSEN
Journal:  Klin Wochenschr       Date:  1960-04-01

3.  Growth characteristics in HeLa cells of the rapidly growing acid fast bacteria, Mycobacterium fortuitum, Mycobacterium phlei, and Mycobacterium smegmatis.

Authors:  C C SHEPARD
Journal:  J Bacteriol       Date:  1957-06       Impact factor: 3.490

4.  Gentamicin as a bactericidal antibiotic in tissue culture.

Authors:  A B Fischer
Journal:  Med Microbiol Immunol       Date:  1975       Impact factor: 3.402

5.  Improved technique for the reversion of Histoplasma capsulatum in tissue culture.

Authors:  N E Wagoner; A L Morehart; H W Larsh
Journal:  Mycopathol Mycol Appl       Date:  1965-06-15

Review 6.  Mammalian cell entry gene family of Mycobacterium tuberculosis.

Authors:  Fan Zhang; Jian-Ping Xie
Journal:  Mol Cell Biochem       Date:  2011-01-22       Impact factor: 3.396

7.  Suppressive activity of streptomycin on the growth of Mycobacterium lepraemurium in macrophage cultures.

Authors:  Y T Chang
Journal:  Appl Microbiol       Date:  1969-05

8.  Uptake of h-dihydrostreptomycin by macrophages in culture.

Authors:  P F Bonventre; J G Imhoff
Journal:  Infect Immun       Date:  1970-07       Impact factor: 3.441

9.  Multiplication of Mycobacterium tuberculosis Within Normal and "Immune" Mouse Macrophages Cultivated With and Without Streptomycin.

Authors:  R J Patterson; G P Youmans
Journal:  Infect Immun       Date:  1970-01       Impact factor: 3.441

10.  A comparison of the growth of selected mycobacteria in HeLa, monkey kidney, and human amnion cells in tissue culture.

Authors:  C C SHEPARD
Journal:  J Exp Med       Date:  1958-02-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.